Delivery Order SPE2DB22D3016-SPE2DB25FBJN5
- Not listed
- The Defense Logistics Agency awarded a $25,585.02 delivery order to AmerisourceBergen Drug Corp for VYVGART (efgartigimod) 400 mg/20 ml vials on August 18, 2025, with a completion deadline of September 9, 2025. This firm fixed-price order represents a competitively awarded, non-set-aside contract for the supply of this specialty pharmaceutical product to support military and federal healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $25,585.02 to AmerisourceBergen Drug Corp for Vyvgart 400 mg/20 mL vials on October 20, 2025, with completion expected by November 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialized pharmaceutical product used in the treatment of autoimmune conditions, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 ml vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of Vyvgart 400 mg/20 ml vials on October 28, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvgart is a specialty pharmaceutical product used in the treatment of autoimmune...
- The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Vyvgart (efgartigimod) 400 mg/20 mL vials, a specialty pharmaceutical product used in treating autoimmune conditions. This competitively awarded, non-set-aside contract carries a ceiling value of $8,528.34 with firm fixed pricing and a completion date of September 17, 2025. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $34,113.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vyvgart 400 mg/20 ml vials. This contract, with an ultimate completion date of October 14, 2025, represents a competitive, non-set-aside award to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- This is a $12,792.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with an ultimate completion date of July 1, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of VYVGART 400 mg/20 ml vials with a ceiling value of $38,377.53. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition in accordance with...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJN5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,792.51 to AmerisourceBergen Drug Corp for VYVGART 400 mg/20 mL vials on September 16, 2025, with completion targeted for October 7, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. VYVGART (efgartigimod) is a specialized pharmaceutical product used in the treatment of autoimmune conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialized medications to support military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic areas to support Defense Health Agency and other government healthcare systems worldwide. The competitively awarded delivery order structure demonstrates the contractor's continued capability to meet federal pharmaceutical supply requirements through the comprehensive prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/16/25 |